Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis
Clinical trial NCT04680975 · TERMINATED
Trial details
- NCT number
- NCT04680975
- Sponsor
- Kadmon, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-03
- Primary completion
- 2022-05-10
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.